FDA — authorised 31 March 2015
- Application: NDA205636
- Marketing authorisation holder: TEVA BRANDED PHARM
- Local brand name: PROAIR RESPICLICK
- Indication: POWDER, METERED — INHALATION
- Status: approved
FDA authorised Albuterol MDPI on 31 March 2015
Yes. FDA authorised it on 31 March 2015.
TEVA BRANDED PHARM holds the US marketing authorisation.